KOMBIGLYZE XR 2.5 mg/1

KOMBIGLYZE XR 2.5 mg/1 combines saxagliptin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

KOMBIGLYZE XR 2.5 mg/1 is used to manage blood sugar levels in adults with type 2 diabetes. This extended-release tablet combines saxagliptin and metformin hydrochloride to help regulate glucose. It is typically prescribed alongside diet and exercise for comprehensive diabetes management.

Common effects of KOMBIGLYZE XR 2.5 mg/1 may include gastrointestinal discomfort, headache, or mild dizziness. Some users report fatigue or nasal congestion. These effects vary and are not experienced by everyone.

Handle KOMBIGLYZE XR 2.5 mg/1 with care, especially if you have kidney or liver issues. Avoid alcohol and stay hydrated. Consult a healthcare provider before use if you have medical conditions or are pregnant.

KOMBIGLYZE XR 2.5 mg/1 may interact with certain medications, including diuretics, NSAIDs, or other diabetes treatments. Alcohol and some supplements can also affect its efficacy. Always inform your healthcare provider about all medications you are taking.